.STUDY HIGHLIGHT.19 September 2024. Plozasiran minimized triglyceride amounts through 80% and lowered the threat of pancreatitis in clients along with relentless chylomicronemia, along with or even without a genetic medical diagnosis.
Daily coverage of global news, financial insights, technological advancements, health tips, and lifestyle trends.
.STUDY HIGHLIGHT.19 September 2024. Plozasiran minimized triglyceride amounts through 80% and lowered the threat of pancreatitis in clients along with relentless chylomicronemia, along with or even without a genetic medical diagnosis.